CLINICAL_TRIALS trial_result · 2023-11-29

Clinical Trial Update: A Trial to Find the Safe Dose for BI 905681 in Patients With Incurable Tumours or Tumours That Have Spread [Phase 1]

A Phase 1 trial aimed at identifying a safe dose of BI 905681 in patients with incurable or metastatic tumours has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Boehringer Ingelheim | Conditions: Neoplasms | Phase 1 | Status: COMPLETED | Results posted: 2023-11-29